Introduction
Living with polycythemia vera (PV) can create ongoing health concerns related to abnormal blood cell production and an increased risk of serious complications such as blood clots, stroke, and cardiovascular events. Managing this rare chronic blood disorder often requires long-term treatment, regular laboratory monitoring, and ongoing care from hematology specialists.
Besremi is a long-acting interferon therapy approved for adults with polycythemia vera. The medication is designed to help regulate abnormal blood cell production in the bone marrow and support long-term control of elevated blood counts associated with the disease.
Polycythemia vera occurs when the bone marrow produces too many red blood cells. In some patients, elevated blood counts may thicken the blood and increase the risk of circulation-related complications. Treatment goals often focus on controlling hematocrit levels, reducing symptoms, and lowering long-term risks associated with excessive blood cell production.
Besremi uses a monopegylated interferon alfa formulation that allows for less frequent dosing compared to some older interferon therapies. Many patients begin treatment with injections every two weeks. Some may later transition to dosing every four weeks, depending on treatment response and blood count stability.
For some individuals, Besremi may help reduce the need for repeated phlebotomy procedures used to remove excess blood. Clinical studies demonstrated durable hematologic responses and improved blood count control in many treated patients.
Although Besremi may provide important long-term disease management benefits, specialty hematology medications can also create financial concerns. Patients may face high specialty pharmacy costs, insurance prior authorization requirements, ongoing laboratory monitoring expenses, and treatment-related out-of-pocket costs.
Those struggling financially and looking for ways to save on their Besremi prescription may benefit from enrolling with Prescription Hope. We offer medication access through patient assistance programs and advocate on your behalf throughout the entire application process and beyond.
Understanding how Besremi works, potential side effects, treatment benefits, and available medication access resources can help patients feel more informed when discussing treatment options with their hematology provider.
What Is the Besremi Patient Assistance Program?
The Besremi patient assistance program provides qualified individuals access to affordable Besremi. This polycythemia vera medication assistance is offered to help patients who are dealing with financial burdens and are unable to afford their Besremi out-of-pocket costs.
When brand-name medications come to market, some are too expensive for most Americans to pay retail for. Pharmaceutical manufacturers understand that some of their products may not be affordable, and therefore often launch Patient Assistance Programs to help patients.
Patient assistance programs offer access to affordable brand-name medications for those who qualify. However, these programs have been known to require patients to go through complicated application processes before getting approved.
There is a solution.
How Expert Advocates Help Make Besremi More Affordable
Professional Application Management
Prescription Hope provides professional application management as well as full medication access management. This means that Prescription Hope’s team of advocates works on your behalf throughout the entire application process.
Our patient advocates complete your forms, collect all needed documents, communicate with healthcare providers to gather necessary signatures, submit your application, and continue to follow up with the manufacturer.
Besremi Price Comparison
vs
Estimated Retail Price*
30-Day Supply
Prescription Hope Price
Per Month, NO Matter The Retail Price
*Source: Drugs.com
Predictable Monthly Pricing
Those seeking affordable Besremi and who qualify can access Besremi by enrolling in the Besremi Patient Assistance Program through Prescription Hope for $70.00 per month, per medication.
For a simple monthly service fee, patients not only get a highly-trained advocate to walk through the application process, but Prescription Hope will continue to manage important tasks, such as refill scheduling, document updates, yearly renewals, and more.
All for $70.00 per month, per med. That means no hassles, surprises, or complicated pricing systems.
Plus, if you do not qualify for your intended program, Prescription Hope will work to help you find other ways to save. Whether it’s substitute medications and their programs, discount cards, coupons, or other savings options, Prescription Hope will do their best to help you save.
And if we can’t? Then you pay nothing.
Ongoing Advocacy and Refill Support
Not only do patients who qualify for interferon therapy financial assistance get patient advocacy support, but they also continue to receive Prescription Hope’s compassionate service for as long as they are a patient with us.
We handle refill scheduling, document updates, yearly renewals, and more.
Besremi Patient Assistance Eligibility
Each patient assistance program maintains strict eligibility standards. Patients wondering what hematology assistance eligibility looks like should enroll with Prescription Hope to get a clearer picture of what it takes to qualify.
While each program maintains its own criteria, most criteria typically fall into several general categories. Some of those categories include:
Income level: The income threshold of each patient assistance program differs.
Insurance coverage: Every program maintains its own requirement regarding insurance coverage status.
Prescription: All programs maintain a strict requirement that an applicant must have a valid prescription for the brand-name medication they wish to qualify for.
U.S. Resident: All programs require patients to be legal U.S. residents to qualify.
Simple Enrollment With Expert Support
Starting Your Journey
Looking to enroll in Besremi assistance through Prescription Hope? Follow these 6 simple steps to get started:
- Submit Information: Those looking to enroll can start by filling out our online enrollment form.
- Advocate Contact: Once we receive a completed enrollment form, a patient advocate will contact you within 1-2 business days.
- Document Collection: Following a quick prequalification, our team will collect all necessary documents for your application.
- Provider Coordination: Our team will also collect needed healthcare provider signatures.
- Program Submission: After everything is in order, we’ll submit your application package to the manufacturer and follow up throughout the processing stage.
- Medication Delivery: Upon approval, the manufacturer will ship your medication. Typically, medication ships within 2 weeks of approval and is sent directly to your door or doctor’s office.
Prescription Hope is not a manufacturer or a pharmacy, and therefore does not handle medication at any time. All medications are sourced from the manufacturer and shipped directly to your door or doctor’s office.
Medication Delivery and Ongoing Support
Following the initial shipment, Prescription Hope will continue to manage your medication access. This means we handle your refill schedule, document updates, program monitoring, yearly renewals, and more.
Understanding Besremi
How Besremi Works
Besremi works by affecting the immune system and helping regulate abnormal blood cell production in the bone marrow.
The medication is classified as a monopegylated interferon alfa-2b therapy. It is believed to help reduce excessive red blood cell production and suppress abnormal blood-forming cells associated with polycythemia vera.
By helping control hematocrit levels and abnormal blood counts, Besremi may reduce complications associated with excessive blood cell production in some patients.
Its long-acting pegylated formulation allows for less frequent dosing compared to some older interferon therapies. The medication is administered as a subcutaneous injection, typically every two weeks initially, with some patients later transitioning to dosing every four weeks after stabilization.
Patients receiving Besremi generally require ongoing laboratory monitoring throughout treatment to assess blood counts, treatment response, and potential side effects.
What Conditions Does Besremi Treat?
Besremi is FDA-approved for the treatment of:
- Adults with polycythemia vera (PV)
Polycythemia vera is a rare chronic myeloproliferative blood disorder in which the bone marrow produces too many red blood cells. Elevated blood cell production may increase the risk of blood clots, stroke, cardiovascular complications, and circulation problems.
Symptoms of polycythemia vera may include:
- Fatigue
- Headaches
- Dizziness
- Itching
- Shortness of breath
- Enlarged spleen
- Blood clot complications
Treatment goals often focus on lowering blood counts, controlling symptoms, reducing clotting risks, and improving long-term disease management.
Besremi is commonly managed by hematologists experienced in treating myeloproliferative disorders and chronic blood cancers.
Benefits of Treatment
For some patients with polycythemia vera, Besremi may provide important long-term disease management benefits by helping regulate abnormal blood cell production.
Potential benefits of Besremi treatment may include:
- Long-term control of polycythemia vera
- Reduction in excessive red blood cell production
- Improved hematocrit and blood count control
- Reduced the need for therapeutic phlebotomy procedures in some patients
- Convenient dosing every 2 to 4 weeks
- Durable hematologic responses were demonstrated in clinical studies
Because polycythemia vera is a chronic condition, treatment plans are individualized based on blood counts, symptom severity, clotting risk, and treatment tolerability.
Patients receiving Besremi typically require ongoing laboratory monitoring and follow-up care to help evaluate treatment effectiveness and manage side effects.
Important Safety Information and Side Effects
Besremi carries important safety risks associated with interferon therapy, including an FDA boxed warning for serious or life-threatening neuropsychiatric, autoimmune, ischemic, and infectious disorders.
Patients should discuss the risks and benefits of treatment carefully with their healthcare provider before starting therapy.
Serious neuropsychiatric effects may occur during treatment, including:
- Depression
- Mood changes
- Suicidal thoughts
- Behavioral changes
Patients should promptly report mood or behavior changes to their healthcare provider.
Common side effects associated with Besremi may include:
- Fatigue
- Joint pain
- Flu-like symptoms
- Headache
- Injection site reactions
- Muscle pain
- Elevated liver enzymes
- Low white blood cell counts
- Depression or mood changes
Additional serious safety concerns may include:
- Autoimmune disorders
- Liver toxicity
- Serious infections
- Serious eye disorders, including retinopathy and vision changes
- Cardiovascular and ischemic events
- Lung toxicity
- Bone marrow suppression
- Pancreatitis
- Dental and periodontal disorders
Patients should seek medical attention if they experience symptoms such as:
- Chest pain
- Breathing problems
- Severe fatigue
- Vision changes
- Signs of infection
Regular monitoring during treatment may include:
- Complete blood counts
- Liver function testing
- Mental health assessments
- Thyroid function monitoring
Interferon therapy may affect thyroid function and require ongoing evaluation during treatment.
Patients with pre-existing autoimmune disorders or mental health conditions may require careful assessment before beginning therapy.
Pregnancy and breastfeeding risks should also be discussed with a healthcare provider prior to treatment.
Access to Multiple Medications
Need more than one name-brand medication? Found hematology medication support and specialty medication assistance, yet still looking for a few other medications?
We may be able to help. We carry a list of hundreds of available and accessible brand-name medications. We can help you with every medication that you qualify for on our list.
All for $70.00 per month, per medication.
Why Choose Prescription Hope for Besremi Assistance
Experienced Advocacy Support
Prescription Hope has led the medication access service field for 20 years. We continue to provide patient advocacy and support by offering compassionate guidance and care during and after the patient assistance program application process.
We want to help you have peace of mind, so that you can focus on what really matters – quality of life and your loved ones.
Ongoing Medication Management
Our trained advocates continue to work on your behalf even after you’ve received approval and get your medication shipped directly to you or your doctor. We manage the important tasks, such as refill scheduling, document updates, and yearly renewals.
Transparent Monthly Pricing
Prescription Hope’s service fee is a simple $70.00 per month, per medication. No hassle, no hidden fees, no surprises.
Nationwide Medication Access Support
Over two decades, we’ve built a network that includes hundreds of pharmaceutical manufacturers and tens of thousands of healthcare providers. Our list of hundreds of brand-name medications means we may be able to help you access affordable medications.
Those looking to enroll in the Besremi Patient Assistance Program through Prescription Hope can simply fill out our online enrollment form today!
